Used as a key chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports the development of selective enzyme inhibitors and receptor modulators. Commonly employed in the production of fluorinated analogs of therapeutic agents where enhanced metabolic stability and binding affinity are required. The amine functionality allows for easy derivatization, making it valuable in medicinal chemistry for constructing drug-like molecules with improved pharmacokinetic profiles.